One Bio 

$0
2
+$0+0% Tuesday 18:30

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
5,764
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q4 2009
Q1 2010
Q3 2010
Q4 2010
Q1 2011
Q2 2011
Q3 2011
0
0.14
0.28
0.43
Expected EPS
N/A
Actual EPS
0.2153

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONBI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap187.56B
Amgen is a biotech firm that develops innovative therapeutics, directly competing in the biotechnology sector with One Bio.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences operates in the biopharmaceutical field, focusing on drugs for life-threatening diseases, overlapping with One Bio's market.
Biogen
BIIB
Mkt Cap26.03B
Biogen focuses on neurological diseases and advanced biologics, competing in similar biotech niches as One Bio.
Vertex Pharmaceuticals
VRTX
Mkt Cap111.43B
Vertex Pharmaceuticals is known for creating treatments for serious diseases, directly competing with One Bio in the biotech innovation space.
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Regeneron Pharmaceuticals is involved in biopharmaceuticals, particularly in genetics-driven drug discovery, competing with One Bio's biotech solutions.
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.29B
Alnylam Pharmaceuticals works on RNAi therapeutics, a cutting-edge area of biotech that could compete with One Bio's innovative approaches.
Incyte
INCY
Mkt Cap19.09B
Incyte operates in the development of proprietary therapeutics, sharing a competitive landscape with One Bio in the biopharmaceutical sector.
Exelixis
EXEL
Mkt Cap11.76B
Exelixis is a biotechnology company that develops small molecule therapies for cancer, competing in the oncology market with One Bio.
Neurocrine Biosciences
NBIX
Mkt Cap13.21B
Neurocrine Biosciences focuses on neurological and endocrine diseases, competing in specialized biotech areas relevant to One Bio's interests.

About

ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-ecological products and over-the-counter products utilizing the extractions of tobacco leaves and various other plant materials. It produces chemical and herbal extracts for use in a range of health and wellness products, including chemical extracts comprising Solanesol and Coenzyme Q10; and herabal extracts, such as Resveratrol, 5-Hydroxytryptophan, Ganoderma Tea, and powdered and particulate fertilizers. This business unit distributes its products through independent third party distributors, universities, and hospital research centers to the bio-health industry and raw chemical intermediates industry in the People's Republic of China. The OP business unit manufactures various consumer and commercial use health and energy drinks, organic food products, and fertilizers primarily based on bamboo in the People's Republic of China. Its products include boiled bamboo shoot cans, boiled bamboo shoot cans with vacuum packing, boiled mixed vegetables, and boiled seasoned vegetables, as well as Kamameshi, a Japanese rice dish. This segment distributes its products directly to supermarket chains, hotels, hospitals, and restaurants, as well as through a network of independent third party distributors. ONE Bio Corp. exports its products to Japan, southeast Asia, Europe, and North America. The company was formerly known as ONE Holdings, Corp. and changed its name to ONE Bio Corp. in November 2009. ONE Bio Corp. was incorporated in 2000 and is headquartered in Aventura, Florida.
Show more...
CEO
Jian Ming Chan
Employees
358
Country
US
ISIN
US6823232094

Listings

0 Comments

Share your thoughts

FAQ

What is One Bio stock price today?
The current price of ONBI is $0 USD — it has increased by +0% in the past 24 hours. Watch One Bio stock price performance more closely on the chart.
What is One Bio stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange One Bio stocks are traded under the ticker ONBI.
What were One Bio earnings last quarter?
ONBI earnings for the last quarter are 0.22 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does One Bio have?
As of April 07, 2026, the company has 358 employees.
In which sector is One Bio located?
One Bio operates in the Materials sector.
When did One Bio complete a stock split?
The last stock split for One Bio was on September 15, 2010 with a ratio of 1:5.
Where is One Bio headquartered?
One Bio is headquartered in Aventura, US.